Clinical trial Recruiting at 1 site Phase2; Phase3 Interventional Ages 18 and up

Comparing Botox and surgery for stomach drainage during esophagectomy

Official title: Comparative Effectiveness of Intrapyloric Botulinum Toxin Injection Versus Pyloromyotomy for Pyloric Drainage During Esophagectomy: A Registry-Based, Pragmatic Randomized Noninferiority Trial

Run by The Cleveland Clinic · NCT06721520 · Data updated 2026-11-12

This study is testing whether Botox injections can help people who have had esophagus surgery manage delayed stomach emptying just as well as surgery can.

Quick facts

PhasePhase2; Phase3
Study typeInterventional
Ages18 Years and up
SexAll
Enrollment170 (estimated)
SponsorThe Cleveland Clinic
Academic / other
Locations1 site (Cleveland, Ohio)
StatusRecruiting
StartedDecember 3, 2024
Main results expectedDecember 31, 2027
Study endsMay 31, 2028
Registry record updatedFebruary 25, 2026
Trial IDNCT06721520 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults aged 18 and older who are scheduled for elective esophagectomy and can receive either treatment method.

Probably not a fit

Patients undergoing emergency esophagectomy or those with contraindications to Botox, such as certain neuromuscular diseases, will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to evaluate the effectiveness of botulinum toxin (Botox) versus pyloromyotomy for pyloric drainage in patients undergoing elective esophagectomy. It is a pragmatic, registry-based, randomized clinical trial that will compare outcomes related to delayed gastric emptying after surgery. Participants will be randomly assigned to receive either intrapyloric Botox injection or pyloromyotomy, with the goal of determining if Botox is as effective as the surgical method in alleviating symptoms of delayed gastric emptying at six months postoperatively.

Why it matters

Potential benefit: If successful, this study could provide a less invasive alternative to surgery for managing delayed gastric emptying in patients undergoing esophagectomy.

How similar studies have gone: While the use of Botox for gastric drainage is explored in other contexts, this specific comparison with pyloromyotomy is novel and has not been extensively tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* 18 years of age or older
* Undergoing elective esophagectomy (thoracoabdominal, Ivor-Lewis, McKeown)
* Receiving a gastric conduit for alimentary reconstruction
* Technically able to receive either intrapyloric Botox injection or pyloromyotomy as ultimately determined intraoperatively
* Willing and able to provide informed consent
* Willing and able to participate in long-term follow up including study visits and surveys

Exclusion Criteria:

* Undergoing emergent esophagectomy (e.g., for esophageal perforation)
* Patients with underlying neuromuscular disease as Botox would be contraindicated (amyotrophic lateral sclerosis, myasthenia gravis, muscular dystrophies, Lambert-Eaton syndrome)
* Patients undergoing left thoracoabdominal without left cervical neck incision (i.e., Sweet esophagectomy) - excluded due to the extent of gastric resection
* Pregnancy
* Allergy or hypersensitivity to botulinum toxin
* Cannot feasibly receive both pyloric interventions as determined intraoperatively (e.g., patients with central obesity undergoing thoracoabdominal esophagectomy makes for a technically difficult pyloromyotomy)

Where it's running

  • Cleveland Clinic
    Cleveland, Ohio, United States
    Recruiting

Study contacts

  • Principal investigator: Siva Raja, MD — The Cleveland Clinic
  • Study coordinator: Andrew Conner, MD
  • Email: connera5@ccf.org
  • Phone: 216-316-6644

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.